BioSpace News Archive

According to Nova one advisor, the global Retinal Vein Occlusion market was valued at USD 18.2 billion in 2021 and it is expected to hit around USD 34.7 billion by 2030 with a CAGR of 8.4% during the forecast period 2022 to 2030.

SpyGlass Pharma, a privately held ophthalmic therapeutics company, announced 3-month data from a First-in-Human glaucoma treatment trial showing that its breakthrough drug delivery platform lowered intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Palatin Technologies, Inc. announced that Paul Kayne, Ph.D., Vice President of Biological Sciences at Palatin, presented at the Eyecelerator@AAO in Chicago, IL.

Stryker announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ending September 30, 2022 and provide an operational update.

Trefoil Therapeutics announced positive Phase 2 results for TTHX1114 in patients with Fuchs Endothelial Corneal Dystrophy.

ViCapsys Life Sciences, Inc., announced the appointment of Mr. Richard Rosenblum, Dr. Colleen Delaney, and Mr. Charles Farrahar to the Company’s Board of Directors, effective September 22, 2022.

Encompass Health Corp. announced it will report results for its third quarter ended Sept. 30, 2022, after the market closes on Oct. 26, 2022.

Invacare Corporation announced that it received notice from the New York Stock Exchange that the company is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s Common Shares was less than $1.00 per share over a consecutive 30 trading-day period.

Medexus Pharmaceuticals entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust.

Helius Medical Technologies, Inc. announced that Dane Andreeff, President and Chief Executive Officer, and Jeff Mathiesen, Chief Financial Officer, will present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference, as follows.